Literature DB >> 14596603

A transient intermediate in the reaction catalyzed by (S)-mandelate dehydrogenase from Pseudomonas putida.

Asteriani R Dewanti1, Bharati Mitra.   

Abstract

(S)-Mandelate dehydrogenase from Pseudomonas putida is a member of a FMN-dependent enzyme family that oxidizes (S)-alpha-hydroxyacids to alpha-ketoacids. The reductive half-reaction consists of the steps involved in substrate oxidation and FMN reduction. In this study, we investigated the mechanism of this half-reaction in detail. At low temperatures, a transient intermediate was formed in the course of the FMN reduction reaction. This intermediate is characteristic of a charge-transfer complex of oxidized FMN and an electron-rich donor and is formed prior to full reduction of the flavin. The intermediate was not due to binding of anionic substrates or inhibitors. It was only observed with efficient substrates that have high k(cat) values. At higher temperatures, it was formed within the dead time of the stopped-flow instrument. The rate of formation of the intermediate was 3-4-fold faster than its rate of disappearance; the former had a larger isotope effect. This suggests that the charge-transfer donor is an electron-rich carbanion/enolate intermediate that is generated by the base-catalyzed abstraction of the substrate alpha-proton. This is consistent with the observation that the intermediate was not observed with the R277K and R277G mutants, which have been shown to destabilize the carbanion intermediate (Lehoux, I. E., and Mitra, B. (2000) Biochemistry 39, 10055-10065). Thus, the MDH reaction has two rate-limiting steps of similar activation energies: the formation and breakdown of a distinct intermediate, with the latter step being slightly more rate limiting. We also show that MDH is capable of catalyzing the reverse reaction, the reoxidation of reduced MDH by the product ketoacid, benzoylformate. The transient intermediate was observed during the reverse reaction as well, confirming that it is indeed a true intermediate in the MDH reaction pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596603     DOI: 10.1021/bi035349o

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Stereoselective biotransformation of racemic mandelic acid using immobilized laccase and (S)-mandelate dehydrogenase.

Authors:  Xing Chen; Chengli Yang; Peng Wang; Xuan Zhang; Bingxin Bao; Dali Li; Ruofu Shi
Journal:  Bioresour Bioprocess       Date:  2017-01-03

2.  Structure of human glycolate oxidase in complex with the inhibitor 4-carboxy-5-[(4-chlorophenyl)sulfanyl]-1,2,3-thiadiazole.

Authors:  Jean Marie Bourhis; Caroline Vignaud; Nicolas Pietrancosta; Françoise Guéritte; Daniel Guénard; Florence Lederer; Ylva Lindqvist
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-11-27

3.  Elucidating the significance of beta-hydride elimination and the dynamic role of acid/base chemistry in a palladium-catalyzed aerobic oxidation of alcohols.

Authors:  Jaime A Mueller; Christopher P Goller; Matthew S Sigman
Journal:  J Am Chem Soc       Date:  2004-08-11       Impact factor: 15.419

4.  Structures of the G81A mutant form of the active chimera of (S)-mandelate dehydrogenase and its complex with two of its substrates.

Authors:  Narayanasami Sukumar; Asteriani Dewanti; Angelo Merli; Gian Luigi Rossi; Bharati Mitra; F Scott Mathews
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-05-15

5.  Conformational flexibility related to enzyme activity: evidence for a dynamic active-site gatekeeper function of Tyr(215) in Aerococcus viridans lactate oxidase.

Authors:  Thomas Stoisser; Michael Brunsteiner; David K Wilson; Bernd Nidetzky
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

6.  Enantioselective cascade biocatalysis for deracemization of 2-hydroxy acids using a three-enzyme system.

Authors:  Ya-Ping Xue; Hao Zeng; Xiao-Lu Jin; Zhi-Qiang Liu; Yu-Guo Zheng
Journal:  Microb Cell Fact       Date:  2016-09-22       Impact factor: 5.328

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.